The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
复制标题
UVB联合卡泊三醇对慢性斑块型银屑病患者全身钙稳态的影响
DOI:
10.1111/j.1365-2230.1997.tb01090.x
复制
发表时间:
1997
影响因子:
4.1
通讯作者:
P.E.H. Tchinson
中科院分区:
文献类型:
--
作者:
J. F. Burke;S. Iqbal;P.E.H. Tchinson
We studied the effects of combining topical calcipotriol, used at the maximal licensed dose, and narrow‐band short wave ultraviolet light (TL01) on systemic calcium homeostasis in the treatment of chronic plaque psoriasis. Patients were randomized in an open fashion to receive either UVB alone, UVB plus 100 g of calcipotriol (50 μg/g) ointment per week or calcipotriol ointment alone (100 g/week). With the exception of a slight increase in serum phosphate in the group receiving combination therapy (from 0·92 to 1·22 mmol/l; P= 0·046), no differences were observed between or within the groups. Psoriasis area and severity scores (PASI) improved to a greater extent in those patients receiving both UVB and calcipotriol (P= 0·045). The combination of UVB and calcipotriol is a safe, effective treatment for chronic plaque psoriasis.